MATTHEW SCHWANKE: Open Payments
NPI 1851674717 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$471 in 13 payments from 9 companies in 2025. Trend: 2023 $193 · 2024 $0 · 2025 $471
Food & beverage: $471
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $198 |
| GlaxoSmithKline, LLC. | 1 | $125 |
| Abbott Laboratories | 1 | $30 |
| SANOFI-AVENTIS U.S. LLC | 1 | $26 |
| Seqirus USA Inc | 1 | $25 |
| Grifols USA, LLC | 1 | $20 |
| Insulet Corporation | 1 | $17 |
| Lilly USA, LLC | 1 | $15 |
| Echosens North America, Inc. | 1 | $15 |
Products named: Ozempic, AREXVY, ETERNA, TZIELD, Fluad, Prolastin-C Liquid, Omnipod, Wegovy.
Industry payments across NC — which companies pay providers there.
